Slide 1Bias Correction in Pharmaceutical Risk-Benefit Assessment Bob Obenchain, PhD, FASA Risk-Benefit Statistics LLC Yin = Dark = Evil = Risk Yang = Light = Good = Benefit…

THE IMPACT OF SELF-MANAGEMENT EDUCATION ON OUTCOMES FOR PATIENTS WITH COPD Joy Gana-Inatimi (Supervisors: Prof MP Dey, Dr CJ Sutton, Mrs HC Stewart) Content ⢠Background…

Slide 1 DRUG-FREE NUTRIENT THERAPY TO HEAL BRAIN IMBALANCES William J. Walsh, Ph.D. Walsh Research Institute Naperville, IL Slide 2 Walsh Research Institute  Nonprofit…

Fellowship Research Goals Cari McCarty, Ph.D. November 2, 2012 Divisions of General Pediatrics and Adolescent Medicine, University of Washington Center for Child Health Behavior…

The Use of Pharmacoeoconomics and Pharmacoepidemiology in Your Local MTF P&T Process by Marv Shepherd, Ph.D. Jim Wilson, Ph.D. Center for Pharmacoeconomic Studies University…

* What do we know about supporting research use by policymakers? What are the challenges that such efforts are striving to overcome? What are some innovative strategies that…

Summary Report of NIH Inclusion Data â FY2005 Carlos E. Caban, Ph.D., M.P.H. Office of Extramural Research, OD NIH October 24, 2006 Overview of the Report Data Executive…

PowerPoint Presentation E-health records research: optimising congenital anomaly data Dr. Shantini Paranjothy Cochrane Institute of Primary Care and Public Health, College…